Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Curi RMB Capital LLC

Curi RMB Capital LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 12.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 35,709 shares of the company's stock after selling 4,927 shares during the quarter. Curi RMB Capital LLC's holdings in Cardinal Health were worth $3,947,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in CAH. Eastern Bank bought a new position in shares of Cardinal Health during the third quarter valued at approximately $25,000. Cultivar Capital Inc. purchased a new position in shares of Cardinal Health in the 2nd quarter valued at $27,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of Cardinal Health in the 2nd quarter valued at $29,000. Hara Capital LLC bought a new position in shares of Cardinal Health in the 3rd quarter worth $31,000. Finally, LRI Investments LLC purchased a new position in Cardinal Health in the first quarter valued at about $32,000. Institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Performance

CAH traded down $2.51 on Friday, hitting $118.78. 2,204,617 shares of the company were exchanged, compared to its average volume of 2,112,748. The business's fifty day moving average is $113.14 and its 200 day moving average is $105.18. The firm has a market capitalization of $28.75 billion, a P/E ratio of 23.11, a price-to-earnings-growth ratio of 1.56 and a beta of 0.60. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $126.14.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company's quarterly revenue was down 4.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.73 EPS. Analysts forecast that Cardinal Health, Inc. will post 7.83 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a dividend of $0.5056 per share. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.70%. Cardinal Health's payout ratio is currently 39.30%.

Analyst Ratings Changes

CAH has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft upped their price target on shares of Cardinal Health from $119.00 to $124.00 and gave the company a "hold" rating in a research note on Monday, November 4th. Barclays boosted their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research note on Monday, November 4th. UBS Group boosted their target price on shares of Cardinal Health from $134.00 to $139.00 and gave the stock a "buy" rating in a research note on Monday, November 4th. Citigroup reduced their price objective on shares of Cardinal Health from $115.00 to $107.00 and set a "neutral" rating for the company in a research report on Friday, July 19th. Finally, Wells Fargo & Company boosted their price objective on Cardinal Health from $95.00 to $101.00 and gave the company an "underweight" rating in a research note on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and an average price target of $123.00.

Insider Buying and Selling at Cardinal Health

In other news, insider Michelle D. Greene sold 4,000 shares of the firm's stock in a transaction on Monday, August 19th. The shares were sold at an average price of $108.85, for a total value of $435,400.00. Following the transaction, the insider now owns 19,242 shares of the company's stock, valued at approximately $2,094,491.70. This trade represents a 17.21 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Jason M. Hollar sold 46,455 shares of the company's stock in a transaction on Monday, August 19th. The stock was sold at an average price of $109.02, for a total transaction of $5,064,524.10. Following the sale, the chief executive officer now directly owns 197,636 shares of the company's stock, valued at approximately $21,546,276.72. This trade represents a 19.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 69,351 shares of company stock worth $7,565,843 in the last quarter. 0.09% of the stock is owned by insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.